Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma.
Gohara S, Shinohara K, Yoshida R, Kariya R, Tazawa H, Hashimoto M, Inoue J, Kubo R, Nakashima H, Arita H, Kawaguchi S, Yamana K, Nagao Y, Iwamoto A, Sakata J, Matsuoka Y, Takeshita H, Hirayama M, Kawahara K, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Okada S, Urata Y, Fujiwara T, Nakayama H. Gohara S, et al. Among authors: nagao y. Mol Ther Oncolytics. 2022 Oct 8;27:141-156. doi: 10.1016/j.omto.2022.10.001. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36381653 Free PMC article.
Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma.
Sakata J, Hirosue A, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, Yamamoto T, Nagata M, Kawaguchi S, Gohara S, Nagao Y, Yamana K, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H. Sakata J, et al. Among authors: nagao y. Cancers (Basel). 2020 Feb 20;12(2):494. doi: 10.3390/cancers12020494. Cancers (Basel). 2020. PMID: 32093285 Free PMC article.
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Yamamoto T, Hirosue A, Nakamoto M, Yoshida R, Sakata J, Matsuoka Y, Kawahara K, Nagao Y, Nagata M, Takahashi N, Hiraki A, Shinohara M, Nakao M, Saitoh N, Nakayama H. Yamamoto T, et al. Among authors: nagao y. Br J Cancer. 2020 Aug;123(4):580-590. doi: 10.1038/s41416-020-0907-6. Epub 2020 Jun 5. Br J Cancer. 2020. PMID: 32499570 Free PMC article.
Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy.
Yoshida R, Gohara S, Sakata J, Matsuoka Y, Hirosue A, Kawahara K, Kawaguchi S, Nagao Y, Yamana K, Nagata M, Fukuma D, Toya R, Murakami R, Hiraki A, Shinohara M, Nakayama H. Yoshida R, et al. Among authors: nagao y. Transl Oncol. 2020 Dec;13(12):100850. doi: 10.1016/j.tranon.2020.100850. Epub 2020 Aug 24. Transl Oncol. 2020. PMID: 32854035 Free PMC article.
Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer.
Kageyama S, Nagao Y, Ma J, Asakawa M, Yoshida R, Takeshita T, Hirosue A, Yamashita Y, Nakayama H. Kageyama S, et al. Among authors: nagao y. Front Cell Infect Microbiol. 2020 Nov 23;10:600884. doi: 10.3389/fcimb.2020.600884. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33330141 Free PMC article.
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma.
Kawahara K, Nagata M, Yoshida R, Hirosue A, Tanaka T, Matsuoka Y, Arita H, Nakashima H, Sakata J, Yamana K, Kawaguchi S, Gohara S, Nagao Y, Hirayama M, Takahashi N, Hirayama M, Nakayama H. Kawahara K, et al. Among authors: nagao y. Biochem Biophys Rep. 2021 Sep 21;28:101114. doi: 10.1016/j.bbrep.2021.101114. eCollection 2021 Dec. Biochem Biophys Rep. 2021. PMID: 34589618 Free PMC article.
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axis.
Yamana K, Inoue J, Yoshida R, Sakata J, Nakashima H, Arita H, Kawaguchi S, Gohara S, Nagao Y, Takeshita H, Maeshiro M, Liu R, Matsuoka Y, Hirayama M, Kawahara K, Nagata M, Hirosue A, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H. Yamana K, et al. Among authors: nagao y. J Extracell Vesicles. 2021 Dec;10(14):e12169. doi: 10.1002/jev2.12169. J Extracell Vesicles. 2021. PMID: 34894384 Free PMC article.
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi S, Kawahara K, Fujiwara Y, Ohnishi K, Pan C, Yano H, Hirosue A, Nagata M, Hirayama M, Sakata J, Nakashima H, Arita H, Yamana K, Gohara S, Nagao Y, Maeshiro M, Iwamoto A, Hirayama M, Yoshida R, Komohara Y, Nakayama H. Kawaguchi S, et al. Among authors: nagao y. Cancer Immunol Immunother. 2022 Sep;71(9):2127-2139. doi: 10.1007/s00262-022-03149-w. Epub 2022 Jan 19. Cancer Immunol Immunother. 2022. PMID: 35044489 Free PMC article.
800 results